TFM
MRNA icon

TFC Financial Management’s Moderna MRNA Stock Holding History

TFC Financial Management’s Portfolio MRNA Stock Details MRNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$18.5K Sell
264
-55
-17% -$2.85K ﹤0.01% 377
2026
Q1 		$16.2K Buy
319
+300
+1,579% +$14K ﹤0.01% 369
2025
Q4 		$561 Sell
19
-106
-85% -$2.88K ﹤0.01% 686
2025
Q3 		$3.22K Buy
+125
New +$3.49K ﹤0.01% 499
2025
Q1 		– Sell
-10
Closed -$416 – 1014
2024
Q4 		$416 Sell
10
-6
-38% -$287 ﹤0.01% 685
2024
Q3 		$1.07K Sell
16
-10
-38% -$918 ﹤0.01% 582
2024
Q2 		$3.09K Buy
26
+5
+24% +$633 ﹤0.01% 438
2024
Q1 		$2.24K Buy
21
+5
+31% +$504 ﹤0.01% 454
2023
Q4 		$1.59K Buy
16
+9
+129% +$757 ﹤0.01% 476
2023
Q3 		$724 Sell
7
-2
-22% -$223 ﹤0.01% 559
2023
Q2 		$1.09K Hold
9
– – ﹤0.01% 508
2023
Q1 		$1.38K Sell
9
-118
-93% -$19.5K ﹤0.01% 490
2022
Q4 		$22.8K Hold
127
– – 0.01% 248
2022
Q3 		$15K Buy
127
+9
+8% +$1.37K ﹤0.01% 277
2022
Q2 		$17K Hold
118
– – 0.01% 272
2022
Q1 		$20K Buy
118
+26
+28% +$4.38K 0.01% 260
2021
Q4 		$23K Sell
92
-100
-52% -$29.2K 0.01% 262
2021
Q3 		$74K Buy
192
+14
+8% +$5.16K 0.02% 183
2021
Q2 		$42K Buy
178
+28
+19% +$5K 0.01% 215
2021
Q1 		$20K Buy
150
+20
+15% +$2.9K 0.01% 255
2020
Q4 		$14K Buy
+130
New +$13.2K 0.01% 291

Other funds holding MRNA

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
TP
Theleme Partners London, United Kingdom $1.68B AUM 19.9% 1-Year Est. Return

TFC Financial Management's MRNA Position: Q2 2026 in Review

TFC Financial Management reduced its Moderna (MRNA) stake by 17% in Q2 2026, selling an estimated $2.85K and leaving 264 shares worth $18.5K. The position accounts for ﹤0.01% of the portfolio, ranked #377.

TFC Financial Management first reported a position in MRNA in Q4 2020 and has held it in 21 quarters since. The position peaked at $74K in Q3 2021. 782 funds tracked by Wall St. Rank hold MRNA as of Q2 2026.

  • TFC Financial Management held 264 shares of Moderna worth $18.5K as of Q2 2026.
  • TFC Financial Management sold 55 Moderna shares in Q2 2026, an estimated $2.85K.
  • Moderna made up ﹤0.01% of TFC Financial Management's portfolio in Q2 2026, its #377 holding.
  • TFC Financial Management first reported a position in Moderna in Q4 2020 and has held it in 21 quarters since.
  • TFC Financial Management's Moderna position peaked at $74K in Q3 2021.
  • 782 funds tracked by Wall St. Rank held Moderna as of Q2 2026.

Based on TFC Financial Management's 13F filing for Q2 2026, filed 23 Jul 2026.